EVANS BLUE Drug Patent Profile
✉ Email this page to a colleague
When do Evans Blue patents expire, and when can generic versions of Evans Blue launch?
Evans Blue is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in EVANS BLUE is evans blue. There are seven drug master file entries for this compound. Additional details are available on the evans blue profile page.
Summary for EVANS BLUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Patent Applications: | 4 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | EVANS BLUE at DailyMed |
Medical Subject Heading (MeSH) Categories for EVANS BLUE
US Patents and Regulatory Information for EVANS BLUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | EVANS BLUE | evans blue | INJECTABLE;INJECTION | 008041-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
